CPC A61K 31/198 (2013.01) [A61P 35/00 (2018.01)] | 19 Claims |
1. A method for treating a cancer having dysregulated polyamine metabolism in a subject in need thereof, wherein the cancer having dysregulated polyamine metabolism is breast cancer, colorectal cancer, pancreatic cancer, or brain cancer, the method comprising administering to the subject a therapeutically effective amount of a dietary product, wherein:
the dietary product comprises at most about 0.5% (w/w) of cysteine or cystine; the dietary product comprises at least about 7.5% (w/w) of methionine;
the therapeutically effective amount of the dietary product is from about 0.5 g/kg/day to about 1 g/kg/day; and
the subject is undergoing a cancer therapy for the cancer having dysregulated polyamine metabolism.
|